Research graph
References from Novel Bioactive Peptides Inducing <scp>ROS</scp> ‐Mediated Apoptosis in Colorectal Cancer Cells. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · External reference
Colorectal Cancer Statistics, 2020
2020 · External reference
Unresolved reference
2017 · External reference
Anticancer Peptide: Physicochemical Property, Functional Aspect and Trend in Clinical Application
10.3892/ijo.2020.5099 · 2020 · External reference
Design and Synthesis of Bioinspired Benzocoumarin‐Chalcones Chimeras as Potential Anti‐Breast Cancer Agents
10.1002/slct.202101853 · 2021 · External reference
A Novel Benzocoumarin‐Stilbene Hybrid as a DNA Ligase I Inhibitor With In Vitro and In Vivo Anti‐Tumor Activity in Breast Cancer Models
10.1038/s41598-017-10864-3 · 2017 · External reference
Pseudo‐Natural Products: Expanding Chemical and Biological Space by Surpassing Natural Constraints
10.1016/j.bioorg.2024.107525 · 2024 · External reference
Coumarins as Versatile Therapeutic Phytomolecules: A Systematic Review
10.1016/j.phymed.2024.155972 · 2024 · External reference
Primed for Global Coronavirus Pandemic: Emerging Research and Clinical Outcome
10.1016/j.ejmech.2020.112862 · 2021 · External reference
Current Research Status of Anti‐Cancer Peptides: Mechanism of Action, Production, and Clinical Applications
10.1016/j.biopha.2023.114996 · 2023 · External reference
Exploring the Anticancer Potential and Mechanisms of Action of Natural Coumarins and Isocoumarins
10.1016/j.ejmech.2024.117088 · 2025 · External reference
A View on Drug Resistance in Cancer
10.1038/s41586-019-1730-1 · 2019 · External reference
Recent Advances in the Targeting of Human DNA Ligase I as a Potential New Strategy for Cancer Treatment
10.1016/j.ejmech.2019.111657 · 2019 · External reference
Drug Resistance in Cancer: Mechanisms and Tackling Strategies
10.1007/s43440-020-00138-7 · 2020 · External reference
Therapeutic Peptides: Current Applications and Future Directions
10.1038/s41392-022-00904-4 · 2022 · External reference
Trends in Peptide Drug Discovery
10.1038/s41573-020-00135-8 · 2021 · External reference
Mirror‐Image Protein and Peptide Drug Discovery Through Mirror‐Image Phage Display
10.1016/j.chempr.2024.06.004 · 2024 · External reference
Three Rounds of Stability‐Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX‐315
10.1021/acs.jmedchem.3c02232 · 2024 · External reference
The Hybrid Oncolytic Peptide NTP‐385 Potently Inhibits Adherent Cancer Cells by Targeting the Nucleus
10.1038/s41401-022-00939-x · 2023 · External reference
Advancements in Therapeutic Peptides: Shaping the Future of Cancer Treatment
10.1016/j.bbcan.2024.189197 · 2024 · External reference
Design, Synthesis and Bioactivity Evaluation of Novel Fusion Peptides and Their CPT Conjugates Inducing Effective Anti‐Tumor Responses on HER2 Positive Tumors
10.1016/j.ejmech.2023.116032 · 2024 · External reference
Influence of Chain Length on the Anticancer Activity of the Antimicrobial Peptide CAMEL With Fatty Acid Modification
10.1016/j.ejmech.2022.114557 · 2022 · External reference
Tumor Vasculature‐Targeting PEGylated Peptide‐Drug Conjugate Prodrug Nanoparticles Improve Chemotherapy and Prevent Tumor Metastasis
10.1016/j.ejmech.2021.113430 · 2021 · External reference
Design and Application of Hybrid Cyclic‐Linear Peptide‐Doxorubicin Conjugates as a Strategy to Overcome Doxorubicin Resistance and Toxicity
10.1016/j.ejmech.2021.113836 · 2021 · External reference
Pep5‐Based Antitumor Peptides Containing Multifunctional Fragments With Enhanced Activity and Synergistic Effect
10.1016/j.ejmech.2022.114320 · 2022 · External reference
Sequence Modification of Heptapeptide Selected by Phage Display as Homing Device for HT‐29 Colon Cancer Cells to Improve the Anti‐Tumour Activity of Drug Delivery Systems
10.1016/j.ejmech.2019.05.016 · 2019 · External reference
Recent Advance of Peptide‐Based Molecules and Nonpeptidic Small‐Molecules Modulating PD‐1/PD‐L1 Protein‐Protein Interaction or Targeting PD‐L1 Protein Degradation
10.1016/j.ejmech.2021.113170 · 2021 · External reference
Peptides as Multifunctional Players in Cancer Therapy
10.1038/s12276-023-01016-x · 2023 · External reference
Antimicrobial Peptides: Potential Application in Liver Cancer
10.3389/fmicb.2019.01257 · 2019 · External reference
AntiCP 2.0: An Updated Model for Predicting Anticancer Peptides
10.1093/bib/bbaa153 · 2021 · External reference
Antimicrobial Peptides With Selective Antitumor Mechanisms: Prospect for Anticancer Applications
10.18632/oncotarget.16743 · 2017 · External reference
Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature
10.2174/1389203717666160724200849 · 2017 · External reference
Anticancer Potential of Bioactive Peptides From Animal Sources
10.3892/or.2017.5778 · 2017 · External reference
Anticancer Potential of Natural Peptides From Terrestrial and Marine Environments: A Review
10.1016/j.phytol.2021.02.008 · 2021 · External reference
Design, Synthesis and Anticancer Evaluation of Novel Oncolytic Peptide‐Chlorambucil Conjugates
10.1016/j.bioorg.2023.106674 · 2023 · External reference
PROVENGE (Sipuleucel‐T) in Prostate Cancer: The First FDA‐Approved Therapeutic Cancer Vaccine
10.1158/1078-0432.ccr-10-3126 · 2011 · External reference
Advanced Prostate Cancer: Treatment Advances and Future Directions
10.1016/j.trecan.2020.04.010 · 2020 · External reference
Systemic Therapies for Metastatic Castration‐Resistant Prostate Cancer: An Updated Review
10.5534/wjmh.220200 · 2023 · External reference
Identification of Subtypes of Anticancer Peptides Based on Sequential Features and Physicochemical Properties
10.1038/s41598-021-93124-9 · 2021 · External reference
Current Landscape and Perspective of Oncolytic Viruses and Their Combination Therapies
10.1016/j.tranon.2022.101530 · 2022 · External reference
Therapy With Oncolytic Viruses: Progress and Challenges
10.1038/s41571-022-00719-w · 2023 · External reference
Oncolytic Virotherapy With Myxoma Virus
10.3390/jcm9010171 · 2020 · External reference
Metabolic Signatures Associated With Oncolytic Myxoma Viral Infections
10.1038/s41598-022-15562-3 · 2022 · External reference
Induction of Tumor Cell Autosis by Myxoma Virus‐Infected CAR‐T and TCR‐T Cells to Overcome Primary and Acquired Resistance
10.1016/j.ccell.2022.08.001 · 2022 · External reference
Investigation of Cytotoxicity of Negative Control Peptides Versus Bioactive Peptides on Skin Cancer and Normal Cells: A Comparative Study
10.4155/fmc.12.98 · 2012 · External reference
Design of Potent, Non‐Toxic Anticancer Peptides Based on the Structure of the Antimicrobial Peptide, Temporin‐1CEa
10.1007/s12272-013-0112-8 · 2013 · External reference
Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues With Alkylated Amino Acids, Asparagines, and d‐Amino Acids
10.1021/acs.orglett.7b03363 · 2018 · External reference
Combination of Aspartic Acid and Glutamic Acid Inhibits Tumor Cell Proliferation
10.2220/biomedres.37.153 · 2016 · External reference
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
10.1007/s10989-023-10524-3 · 2023 · External reference
Curved Plane Increases the d Vacancy Population of Pd for Green Production of Cyclohexanone
10.1016/j.chempr.2024.03.022 · 2024 · External reference
Discovery of Novel Tumor‐Targeting Peptide‐Oncolytic Peptide Based Conjugates (PPCs): A New Paradigm for Targeted Oncolytic‐Immunotherapy
10.1016/j.apsb.2026.01.006 · 2026 · External reference
On the Importance of Electrostatic Interactions Between Cell Penetrating Peptides and Membranes: A Pathway Toward Tumor Cell Selectivity?
10.1016/j.biochi.2014.07.022 · 2014 · External reference
Asymmetric Distribution of Phospholipids in Biomembranes
10.1248/bpb.29.1547 · 2006 · External reference
Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
10.1593/neo.101366 · 2011 · External reference
Sphingomyelin and Sphingomyelin Synthase (SMS) in the Malignant Transformation of Glioma Cells and in 2‐Hydroxyoleic Acid Therapy
10.1073/pnas.1115484108 · 2011 · External reference
Reactive Oxygen Species in Cancer
10.3109/10715761003667554 · 2010 · External reference
Physiological Roles of Mitochondrial Reactive Oxygen Species
10.1016/j.molcel.2012.09.025 · 2012 · External reference
Mitochondrial ROS and Cancer Drug Resistance: Implications for Therapy
10.1016/j.phrs.2015.06.013 · 2015 · External reference
Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species
10.1016/j.bbamcr.2016.09.012 · 2016 · External reference
Six‐Transmembrane Epithelial Antigen of the Prostate 1 Protects Against Increased Oxidative Stress via a Nuclear Erythroid 2‐Related Factor Pathway in Colorectal Cancer
10.1038/s41417-018-0056-8 · 2019 · External reference
Induction of G1‐Phase Cell Cycle Arrest and Apoptosis Pathway in MDA‐MB‐231 Human Breast Cancer Cells by Sulfated Polysaccharide Extracted From Laurencia papillosa
10.1186/s12935-016-0315-4 · 2016 · External reference
Antimicrobial Peptide Moricin Induces ROS Mediated Caspase‐Dependent Apoptosis in Human Triple‐Negative Breast Cancer via Suppression of Notch Pathway
10.1186/s12935-023-02958-y · 2023 · External reference
Anti‐Angiogenic Peptides for Cancer Therapeutics
10.2174/138920111796117300 · 2011 · External reference
Novel Anti‐Angiogenic Peptides Derived From ELR‐Containing CXC Chemokines
10.1002/jcb.21712 · 2008 · External reference
Anti‐Cancer Activity of Targeted Pro‐Apoptotic Peptides
10.1038/12469 · 1999 · External reference
Activation of Apoptosis In Vivo by a Hydrocarbon‐Stapled BH3 Helix
10.1126/science.1099191 · 2004 · External reference
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
10.3390/ijms20102383 · 2019 · External reference
Peptide‐Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria
10.1021/acs.accounts.6b00277 · 2016 · External reference
Antimicrobial Peptides and Their Use in Medicine
10.1134/s0003683810090012 · 2010 · External reference
Biophysics in Cancer: The Relevance of Drug‐Membrane Interaction Studies
10.1016/j.bbamem.2016.06.025 · 2016 · External reference
Common and Cell‐Type Specific Responses to Anti‐Cancer Drugs Revealed by High Throughput Transcript Profiling
10.1038/s41467-017-01383-w · 2017 · External reference
Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting
10.1021/acs.jmedchem.7b00163 · 2017 · External reference
Aggregation and Organization of Pardaxin in Phospholipid Membranes. A Fluorescence Energy Transfer Study
10.1016/s0021-9258(19)50456-2 · 1992 · External reference
A Leucine Zipper Motif in the Ectodomain of Sendai Virus Fusion Protein Assembles in Solution and in Membranes and Specifically Binds Biologically‐Active Peptides and the Virus
10.1021/bi971152i · 1997 · External reference
Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines
10.2147/ott.s115055 · 2016 · External reference
Scorpion Venom Causes Apoptosis by Increasing Reactive Oxygen Species and Cell Cycle Arrest in MDA‐MB‐231 and HCT‐8 Cancer Cell Lines
2018 · External reference
Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells
10.3390/nu10060718 · 2018 · External reference
Novel Anti‐Angiogenic Peptides Derived From ELR‐Containing CXC Chemokines
10.1002/jcb.21712 · ExternalCitation · doi-reference
Design and Synthesis of Bioinspired Benzocoumarin‐Chalcones Chimeras as Potential Anti‐Breast Cancer Agents
10.1002/slct.202101853 · ExternalCitation · doi-reference
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
10.1007/s10989-023-10524-3 · ExternalCitation · doi-reference
Design of Potent, Non‐Toxic Anticancer Peptides Based on the Structure of the Antimicrobial Peptide, Temporin‐1CEa
10.1007/s12272-013-0112-8 · ExternalCitation · doi-reference
Drug Resistance in Cancer: Mechanisms and Tackling Strategies
10.1007/s43440-020-00138-7 · ExternalCitation · doi-reference
Discovery of Novel Tumor‐Targeting Peptide‐Oncolytic Peptide Based Conjugates (PPCs): A New Paradigm for Targeted Oncolytic‐Immunotherapy
10.1016/j.apsb.2026.01.006 · ExternalCitation · doi-reference
Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species
10.1016/j.bbamcr.2016.09.012 · ExternalCitation · doi-reference
Biophysics in Cancer: The Relevance of Drug‐Membrane Interaction Studies
10.1016/j.bbamem.2016.06.025 · ExternalCitation · doi-reference
Advancements in Therapeutic Peptides: Shaping the Future of Cancer Treatment
10.1016/j.bbcan.2024.189197 · ExternalCitation · doi-reference
On the Importance of Electrostatic Interactions Between Cell Penetrating Peptides and Membranes: A Pathway Toward Tumor Cell Selectivity?
10.1016/j.biochi.2014.07.022 · ExternalCitation · doi-reference
Design, Synthesis and Anticancer Evaluation of Novel Oncolytic Peptide‐Chlorambucil Conjugates
10.1016/j.bioorg.2023.106674 · ExternalCitation · doi-reference
Pseudo‐Natural Products: Expanding Chemical and Biological Space by Surpassing Natural Constraints
10.1016/j.bioorg.2024.107525 · ExternalCitation · doi-reference
Current Research Status of Anti‐Cancer Peptides: Mechanism of Action, Production, and Clinical Applications
10.1016/j.biopha.2023.114996 · ExternalCitation · doi-reference
Induction of Tumor Cell Autosis by Myxoma Virus‐Infected CAR‐T and TCR‐T Cells to Overcome Primary and Acquired Resistance
10.1016/j.ccell.2022.08.001 · ExternalCitation · doi-reference
Curved Plane Increases the d Vacancy Population of Pd for Green Production of Cyclohexanone
10.1016/j.chempr.2024.03.022 · ExternalCitation · doi-reference
Mirror‐Image Protein and Peptide Drug Discovery Through Mirror‐Image Phage Display
10.1016/j.chempr.2024.06.004 · ExternalCitation · doi-reference
Sequence Modification of Heptapeptide Selected by Phage Display as Homing Device for HT‐29 Colon Cancer Cells to Improve the Anti‐Tumour Activity of Drug Delivery Systems
10.1016/j.ejmech.2019.05.016 · ExternalCitation · doi-reference
Recent Advances in the Targeting of Human DNA Ligase I as a Potential New Strategy for Cancer Treatment
10.1016/j.ejmech.2019.111657 · ExternalCitation · doi-reference
Primed for Global Coronavirus Pandemic: Emerging Research and Clinical Outcome
10.1016/j.ejmech.2020.112862 · ExternalCitation · doi-reference
Recent Advance of Peptide‐Based Molecules and Nonpeptidic Small‐Molecules Modulating PD‐1/PD‐L1 Protein‐Protein Interaction or Targeting PD‐L1 Protein Degradation
10.1016/j.ejmech.2021.113170 · ExternalCitation · doi-reference
Tumor Vasculature‐Targeting PEGylated Peptide‐Drug Conjugate Prodrug Nanoparticles Improve Chemotherapy and Prevent Tumor Metastasis
10.1016/j.ejmech.2021.113430 · ExternalCitation · doi-reference
Design and Application of Hybrid Cyclic‐Linear Peptide‐Doxorubicin Conjugates as a Strategy to Overcome Doxorubicin Resistance and Toxicity
10.1016/j.ejmech.2021.113836 · ExternalCitation · doi-reference
Pep5‐Based Antitumor Peptides Containing Multifunctional Fragments With Enhanced Activity and Synergistic Effect
10.1016/j.ejmech.2022.114320 · ExternalCitation · doi-reference
Influence of Chain Length on the Anticancer Activity of the Antimicrobial Peptide CAMEL With Fatty Acid Modification
10.1016/j.ejmech.2022.114557 · ExternalCitation · doi-reference
Design, Synthesis and Bioactivity Evaluation of Novel Fusion Peptides and Their CPT Conjugates Inducing Effective Anti‐Tumor Responses on HER2 Positive Tumors
10.1016/j.ejmech.2023.116032 · ExternalCitation · doi-reference
Exploring the Anticancer Potential and Mechanisms of Action of Natural Coumarins and Isocoumarins
10.1016/j.ejmech.2024.117088 · ExternalCitation · doi-reference
Physiological Roles of Mitochondrial Reactive Oxygen Species
10.1016/j.molcel.2012.09.025 · ExternalCitation · doi-reference
Mitochondrial ROS and Cancer Drug Resistance: Implications for Therapy
10.1016/j.phrs.2015.06.013 · ExternalCitation · doi-reference
Coumarins as Versatile Therapeutic Phytomolecules: A Systematic Review
10.1016/j.phymed.2024.155972 · ExternalCitation · doi-reference
Anticancer Potential of Natural Peptides From Terrestrial and Marine Environments: A Review
10.1016/j.phytol.2021.02.008 · ExternalCitation · doi-reference
Current Landscape and Perspective of Oncolytic Viruses and Their Combination Therapies
10.1016/j.tranon.2022.101530 · ExternalCitation · doi-reference
Advanced Prostate Cancer: Treatment Advances and Future Directions
10.1016/j.trecan.2020.04.010 · ExternalCitation · doi-reference
Aggregation and Organization of Pardaxin in Phospholipid Membranes. A Fluorescence Energy Transfer Study
10.1016/s0021-9258(19)50456-2 · ExternalCitation · doi-reference
Peptide‐Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria
10.1021/acs.accounts.6b00277 · ExternalCitation · doi-reference
Three Rounds of Stability‐Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX‐315
10.1021/acs.jmedchem.3c02232 · ExternalCitation · doi-reference
Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting
10.1021/acs.jmedchem.7b00163 · ExternalCitation · doi-reference
Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues With Alkylated Amino Acids, Asparagines, and d‐Amino Acids
10.1021/acs.orglett.7b03363 · ExternalCitation · doi-reference
A Leucine Zipper Motif in the Ectodomain of Sendai Virus Fusion Protein Assembles in Solution and in Membranes and Specifically Binds Biologically‐Active Peptides and the Virus
10.1021/bi971152i · ExternalCitation · doi-reference
Anti‐Cancer Activity of Targeted Pro‐Apoptotic Peptides
10.1038/12469 · ExternalCitation · doi-reference
Peptides as Multifunctional Players in Cancer Therapy
10.1038/s12276-023-01016-x · ExternalCitation · doi-reference
Therapeutic Peptides: Current Applications and Future Directions
10.1038/s41392-022-00904-4 · ExternalCitation · doi-reference
The Hybrid Oncolytic Peptide NTP‐385 Potently Inhibits Adherent Cancer Cells by Targeting the Nucleus
10.1038/s41401-022-00939-x · ExternalCitation · doi-reference
Six‐Transmembrane Epithelial Antigen of the Prostate 1 Protects Against Increased Oxidative Stress via a Nuclear Erythroid 2‐Related Factor Pathway in Colorectal Cancer
10.1038/s41417-018-0056-8 · ExternalCitation · doi-reference
Common and Cell‐Type Specific Responses to Anti‐Cancer Drugs Revealed by High Throughput Transcript Profiling
10.1038/s41467-017-01383-w · ExternalCitation · doi-reference
Therapy With Oncolytic Viruses: Progress and Challenges
10.1038/s41571-022-00719-w · ExternalCitation · doi-reference
Trends in Peptide Drug Discovery
10.1038/s41573-020-00135-8 · ExternalCitation · doi-reference
A View on Drug Resistance in Cancer
10.1038/s41586-019-1730-1 · ExternalCitation · doi-reference
A Novel Benzocoumarin‐Stilbene Hybrid as a DNA Ligase I Inhibitor With In Vitro and In Vivo Anti‐Tumor Activity in Breast Cancer Models
10.1038/s41598-017-10864-3 · ExternalCitation · doi-reference
Identification of Subtypes of Anticancer Peptides Based on Sequential Features and Physicochemical Properties
10.1038/s41598-021-93124-9 · ExternalCitation · doi-reference
Metabolic Signatures Associated With Oncolytic Myxoma Viral Infections
10.1038/s41598-022-15562-3 · ExternalCitation · doi-reference
Sphingomyelin and Sphingomyelin Synthase (SMS) in the Malignant Transformation of Glioma Cells and in 2‐Hydroxyoleic Acid Therapy
10.1073/pnas.1115484108 · ExternalCitation · doi-reference
AntiCP 2.0: An Updated Model for Predicting Anticancer Peptides
10.1093/bib/bbaa153 · ExternalCitation · doi-reference
Activation of Apoptosis In Vivo by a Hydrocarbon‐Stapled BH3 Helix
10.1126/science.1099191 · ExternalCitation · doi-reference
Antimicrobial Peptides and Their Use in Medicine
10.1134/s0003683810090012 · ExternalCitation · doi-reference
PROVENGE (Sipuleucel‐T) in Prostate Cancer: The First FDA‐Approved Therapeutic Cancer Vaccine
10.1158/1078-0432.ccr-10-3126 · ExternalCitation · doi-reference
Induction of G1‐Phase Cell Cycle Arrest and Apoptosis Pathway in MDA‐MB‐231 Human Breast Cancer Cells by Sulfated Polysaccharide Extracted From Laurencia papillosa
10.1186/s12935-016-0315-4 · ExternalCitation · doi-reference
Antimicrobial Peptide Moricin Induces ROS Mediated Caspase‐Dependent Apoptosis in Human Triple‐Negative Breast Cancer via Suppression of Notch Pathway
10.1186/s12935-023-02958-y · ExternalCitation · doi-reference
Asymmetric Distribution of Phospholipids in Biomembranes
10.1248/bpb.29.1547 · ExternalCitation · doi-reference
Increased Exposure of Phosphatidylethanolamine on the Surface of Tumor Vascular Endothelium
10.1593/neo.101366 · ExternalCitation · doi-reference
Antimicrobial Peptides With Selective Antitumor Mechanisms: Prospect for Anticancer Applications
10.18632/oncotarget.16743 · ExternalCitation · doi-reference
Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines
10.2147/ott.s115055 · ExternalCitation · doi-reference
Anti‐Angiogenic Peptides for Cancer Therapeutics
10.2174/138920111796117300 · ExternalCitation · doi-reference
Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature
10.2174/1389203717666160724200849 · ExternalCitation · doi-reference
Combination of Aspartic Acid and Glutamic Acid Inhibits Tumor Cell Proliferation
10.2220/biomedres.37.153 · ExternalCitation · doi-reference
Reactive Oxygen Species in Cancer
10.3109/10715761003667554 · ExternalCitation · doi-reference
Antimicrobial Peptides: Potential Application in Liver Cancer
10.3389/fmicb.2019.01257 · ExternalCitation · doi-reference
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
10.3390/ijms20102383 · ExternalCitation · doi-reference
Oncolytic Virotherapy With Myxoma Virus
10.3390/jcm9010171 · ExternalCitation · doi-reference
Induction of Apoptosis and Cytotoxicity by Isothiocyanate Sulforaphene in Human Hepatocarcinoma HepG2 Cells
10.3390/nu10060718 · ExternalCitation · doi-reference
Anticancer Peptide: Physicochemical Property, Functional Aspect and Trend in Clinical Application
10.3892/ijo.2020.5099 · ExternalCitation · doi-reference
Anticancer Potential of Bioactive Peptides From Animal Sources
10.3892/or.2017.5778 · ExternalCitation · doi-reference
Investigation of Cytotoxicity of Negative Control Peptides Versus Bioactive Peptides on Skin Cancer and Normal Cells: A Comparative Study
10.4155/fmc.12.98 · ExternalCitation · doi-reference
Systemic Therapies for Metastatic Castration‐Resistant Prostate Cancer: An Updated Review
10.5534/wjmh.220200 · ExternalCitation · doi-reference
